Schizophrenia Breakthrough: Cobenfy’s FDA Approval Offers New Hope for Patients
Schizophrenia is experiencing a pivotal moment in mental health treatment with the U.S. Food and Drug Administration (FDA) granting approval…
Schizophrenia
Read More
Neurocrine Biosciences Takes Bold Step to Refocus Efforts After Clinical Trial Setback, Reinforcing Commitment to Mental Health Innovation
Neurocrine Biosciences Halts Development of Schizophrenia Drug After Trial Failure Neurocrine Biosciences, in a significant setback, has announced that it…